Compare GLNG & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GLNG | SXTC |
|---|---|---|
| Founded | 1946 | 2005 |
| Country | Bermuda | China |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 92.9M |
| IPO Year | 2002 | 2017 |
| Metric | GLNG | SXTC |
|---|---|---|
| Price | $49.71 | $2.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $50.63 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 652.6K |
| Earning Date | 11-21-2023 | 08-19-2019 |
| Dividend Yield | ★ 1.85% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3.14 | N/A |
| Revenue Next Year | $8.66 | N/A |
| P/E Ratio | $80.48 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $35.02 | $0.03 |
| 52 Week High | $57.79 | $6.98 |
| Indicator | GLNG | SXTC |
|---|---|---|
| Relative Strength Index (RSI) | 41.08 | 51.46 |
| Support Level | $48.19 | $1.86 |
| Resistance Level | $51.99 | $2.81 |
| Average True Range (ATR) | 1.23 | 0.28 |
| MACD | -0.25 | 0.00 |
| Stochastic Oscillator | 5.83 | 65.57 |
Golar LNG Ltd designs, converts, owns, and operates marine infrastructure for the liquefaction of natural gas and provides floating liquefied natural gas (FLNG) services. It offers solutions for gas resource holders to develop and utilize gas reserves, including stranded, associated, flared, or underutilized resources. The company's reportable segments are: i) FLNG: includes the operations of FLNG vessels and projects, and ii) Corporate and other: includes legacy shipping segment activities, vessel management, floating storage and regasification unit services for third parties. The majority of the company's revenue is derived from the FLNG segment. Geographically, it generates the maximum revenue from Cameroon.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly TCMP (Directed-oral TCMP and After-soaking TCMP), which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.